Researchers reviewed 100 popular videos with nearly 46 million views. None were labeled as ads, though promoting prescription drugs is illegal in the UK.
Recap by typeshit. Full story at NonStop Local KHQ.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Novo Nordisk's newest Wegovy injection puts fresh pressure on rivals in the race to lead obesity treatment, The Times reports.
NPR counted over 1,000 FDA reports of optic neuropathy tied to GLP-1s since 2024. Novo Nordisk calls the claims meritless and Lilly says it will fight them.
Loading…